SCHEMBL7959068

SCHEMBL7959068

C=C/C=C(\C=C(\C)N)c1ccc(NC(=O)Nc2cccc(OCCC)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ MAPT P10636 7/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ FAAH O00519 1/20 0.44
▸ LMNA P02545 4/20 0.43
▸ NPC1 O15118 5/20 0.43
▸ RAB9A P51151 5/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ TSHR P16473 3/20 0.41
▸ TP53 P04637 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ PAX8 Q06710 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ PLAU P00749 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955623 0.92 NPC1 (0.50) NR1H4MAPTSMN1; SMN2LMNANPC1
SCHEMBL7969315 0.85 CA2 (0.54) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL7969958 0.83 MEN1 (0.48) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL7969314 0.82 KMT2A (0.56) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL7970519 0.82 CNR1 (0.57) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL7957018 0.81 CSF1R (0.52) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL7968563 0.81 RAB9A (0.55) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL7959052 0.80 HPSE (0.42) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL7966117 0.80 RAF1 (0.48) NR1H4MAPTSMN1; SMN2LMNANPC1
SCHEMBL7973003 0.79 MEN1 (0.48) MAPTSMN1; SMN2LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 — — WO disclosed
Send feedback